Medifast, Inc. (MED)
12.00
+0.05
(+0.42%)
USD |
NYSE |
Aug 24, 16:00
12.02
+0.02
(+0.12%)
Pre-Market: 20:00
Medifast Total Liabilities (Quarterly) : 64.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.02M |
| March 31, 2026 | 54.36M |
| December 31, 2025 | 58.09M |
| September 30, 2025 | 53.50M |
| June 30, 2025 | 53.33M |
| March 31, 2025 | 69.05M |
| December 31, 2024 | 83.12M |
| September 30, 2024 | 83.90M |
| June 30, 2024 | 88.25M |
| March 31, 2024 | 91.80M |
| December 31, 2023 | 124.77M |
| September 30, 2023 | 126.98M |
| June 30, 2023 | 133.16M |
| March 31, 2023 | 150.71M |
| December 31, 2022 | 177.74M |
| September 30, 2022 | 175.83M |
| June 30, 2022 | 211.07M |
| March 31, 2022 | 205.41M |
| December 31, 2021 | 209.98M |
| September 30, 2021 | 175.13M |
| June 30, 2021 | 169.54M |
| March 31, 2021 | 151.50M |
| December 31, 2020 | 126.60M |
| September 30, 2020 | 120.78M |
| June 30, 2020 | 115.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 91.39M |
| December 31, 2019 | 94.23M |
| September 30, 2019 | 87.39M |
| June 30, 2019 | 86.55M |
| March 31, 2019 | 88.00M |
| December 31, 2018 | 62.30M |
| September 30, 2018 | 62.81M |
| June 30, 2018 | 53.44M |
| March 31, 2018 | 38.19M |
| December 31, 2017 | 37.35M |
| September 30, 2017 | 26.25M |
| June 30, 2017 | 25.34M |
| March 31, 2017 | 23.78M |
| December 31, 2016 | 25.20M |
| September 30, 2016 | 28.53M |
| June 30, 2016 | 26.81M |
| March 31, 2016 | 29.51M |
| December 31, 2015 | 27.53M |
| September 30, 2015 | 27.61M |
| June 30, 2015 | 29.18M |
| March 31, 2015 | 35.44M |
| December 31, 2014 | 35.43M |
| September 30, 2014 | 32.79M |
| June 30, 2014 | 32.23M |
| March 31, 2014 | 34.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| United Natural Foods, Inc. | 5.588B |
| Integrated BioPharma, Inc. | 7.687M |
| BioForce Nanosciences Holdings, Inc. | 0.0848M |
| Skinvisible, Inc. | 10.91M |
| Nevis Brands, Inc. | 0.5354M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 260.40M |
| Shareholders Equity (Quarterly) | 196.38M |
| Debt to Equity Ratio | 0.1406 |
| Current Ratio | 4.861 |
| Net Debt Paydown Yield | -2.19% |